*	OR T2 T3
R1	Has_multiplier Arg1:T2 Arg2:T1	
*	OR T6 T7
R2	Has_temporal Arg1:T6 Arg2:T5	
*	OR T2 T6 T9
R3	Has_qualifier Arg1:T11 Arg2:T12	
R4	Has_temporal Arg1:T11 Arg2:T10	
R5	Has_negation Arg1:T14 Arg2:T13	
R6	AND Arg1:T11 Arg2:T14	
*	OR T16 T17
R7	Has_qualifier Arg1:T11 Arg2:T16	
R8	Has_temporal Arg1:T11 Arg2:T18	
*	OR T21 T22 T23
R9	Has_temporal Arg1:T26 Arg2:T25	
R10	Has_negation Arg1:T26 Arg2:T24	
R11	AND Arg1:T21 Arg2:T26	
R12	Has_qualifier Arg1:T21 Arg2:T28	
R13	Subsumes Arg1:T30 Arg2:T31	
T1	Multiplier 31 39	multiple
T2	Procedure 40 51;73 84	solid organ transplants
T3	Procedure 55 84	islet cell tissue transplants
T5	Temporal 94 104	previously
T6	Procedure 117 122;133 143	organ transplant
T7	Procedure 126 143	tissue transplant
T9	Procedure 165 197	combined liver-kidney transplant
T10	Temporal 200 207	History
T11	Condition 211 221	malignancy
T12	Qualifier 225 241	any organ system
T13	Negation 243 253	other than
T14	Condition 254 296	localized basal cell carcinoma of the skin
T16	Qualifier 299 306	treated
T17	Qualifier 310 319	untreated
T18	Temporal 321 344	within the past 5 years
T19	Non-representable 346 419	regardless of whether there is evidence of local recurrence or metastases
T21	Condition 439 447;467 477	surgical conditions
T22	Condition 449 456;467 477	medical conditions
T23	Condition 460 477	mental conditions
T24	Negation 479 489	other than
T25	Temporal 494 501	current
T26	Procedure 502 517	transplantation
T28	Qualifier 562 610	might interfere with the objectives of the study
T29	Condition 613 621	Pregnant
T30	Observation 625 632	nursing
T31	Observation 634 643	lactating
T32	Person 645 650	women
